Literature DB >> 793541

Consumptive opsoninopathy: possible pathogenesis in lethal and opportunistic infections.

J W Alexander, M A McClellan, C K Ogle, J D Ogle.   

Abstract

Serum levels of properdin, Factor B and C3 and the ability of these sera to opsonize E. coli 075 were measured in 17 patients with surgical infections ranging in severity from mild to fatal. There was good direct correlation between severity of infection, serum levels of properdin and C3, and the ability of the serum to support opsonization. The levels of Factor B were not significantly reduced when measured by radial immunodiffusion, but immunoelectrophoresis showed conversion. Restoration of full opsonic activity was accomplished only by the addition of a combination of C3, Factor B, and properdin in excess. The findings provide evidence that severe bacterial infection causes a consumption of opsonic proteins which may result in a reduced ability of the patient's serum to opsonize bacteria and thereby further increase susceptibility to infection.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 793541      PMCID: PMC1345405          DOI: 10.1097/00000658-197612000-00002

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  22 in total

Review 1.  Complement.

Authors:  H J Müller-Eberhard
Journal:  Annu Rev Biochem       Date:  1975       Impact factor: 23.643

2.  THE INITIAL STAGE OF CANINE ENDOTOXIN SHOCK AS AN EXPRESSION OF ANAPHYLACTIC SHOCK: STUDIES ON COMPLEMENT TITERS AND PLASMA HISTAMINE CONCENTRATIONS.

Authors:  W W SPINK; R B DAVIS; R POTTER; S CHARTRAND
Journal:  J Clin Invest       Date:  1964-04       Impact factor: 14.808

3.  Properties of highly purified human properdin.

Authors:  J Ensky; C F Hinz; E W Todd; R J Wedgwood; J T Boyer; I H Lepow
Journal:  J Immunol       Date:  1968-01       Impact factor: 5.422

4.  Homozygous deficiency of C3 in a patient with repeated infections.

Authors:  C A Alper; H R Colten; F S Rosen; A R Rabson; G M Macnab; J S Gear
Journal:  Lancet       Date:  1972-12-02       Impact factor: 79.321

5.  The potential pathogenic role of complement in dengue hemorrhagic shock syndrome.

Authors:  V A Bokisch; F H Top; P K Russell; F J Dixon; H J Müller-Eberhard
Journal:  N Engl J Med       Date:  1973-11-08       Impact factor: 91.245

6.  Increased susceptibility to infection in a patient with type II essential hypercatabolism of C3.

Authors:  C A Alper; K J Bloch; F S Rosen
Journal:  N Engl J Med       Date:  1973-03-22       Impact factor: 91.245

7.  Biologic role of rheumatoid factor? Relationship between antiglobulin consumption and complement system activation during bacteremia in man.

Authors:  G L Bach; C M Blain; T O Anderson; R M Gunnar
Journal:  Acta Biol Med Ger       Date:  1973

8.  Improved tests for the evaluation of neutrophil function in human disease.

Authors:  J W Alexander; D B Windhorst; R A Good
Journal:  J Lab Clin Med       Date:  1968-07

9.  Leukocyte function and the development of opsonic and complement activity in the neonate.

Authors:  G H McCracken; H F Eichenwald
Journal:  Am J Dis Child       Date:  1971-02

10.  Reduction of serum complement in rabbits after injection of endotoxin.

Authors:  V E GILBERT; A I BRAUDE
Journal:  J Exp Med       Date:  1962-10-01       Impact factor: 14.307

View more
  22 in total

1.  Polymorphonuclear leukocyte function and serum opsonic activity in surgical patients.

Authors:  T Inoue; M Obata; Y Mishima
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

2.  Chronological changes in the complement system in sepsis.

Authors:  H Nakae; S Endo; K Inada; M Yoshida
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

3.  A systematic study of host defense processes in badly injured patients.

Authors:  H C Polk; C D George; S R Wellhausen; K Cost; P R Davidson; M P Regan; A P Borzotta
Journal:  Ann Surg       Date:  1986-09       Impact factor: 12.969

4.  Fibronectin degradation products containing the cytoadhesive tetrapeptide stimulate human neutrophil degranulation.

Authors:  Y T Wachtfogel; W Abrams; U Kucich; G Weinbaum; M Schapira; R W Colman
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

5.  Sepsis in trauma patients.

Authors:  C C Baker; D C Hohn; D D Trunkey; F W Blaisdell
Journal:  West J Med       Date:  1979-04

6.  Quantitation of the third component of human complement attached to the surface of opsonized bacteria: opsonin-deficient sera and phagocytosis-resistant strains.

Authors:  H A Verbrugh; W C van Dijk; M E van Erne; R Peters; P K Peterson; J Verhoef
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

7.  Opsonic alpha2 surface binding glycoprotein therapy during sepsis.

Authors:  W A Scovill; T M Saba; F A Blumenstock; H Bernard; S R Powers
Journal:  Ann Surg       Date:  1978-10       Impact factor: 12.969

8.  Opsonic activity of blister fluid from burn patients.

Authors:  E A Deitch
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

9.  Purified fibronectin administration to patients with severe abdominal infections. A controlled clinical trial.

Authors:  P Lundsgaard-Hansen; J E Doran; E Rubli; E Papp; J J Morgenthaler; P Späth
Journal:  Ann Surg       Date:  1985-12       Impact factor: 12.969

10.  A sequential, prospective analysis of immunologic abnormalities and infection following severe thermal injury.

Authors:  J W Alexander; C K Ogle; J D Stinnett; B G Macmillan
Journal:  Ann Surg       Date:  1978-12       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.